Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial is a research paper published in Research and Practice in Thrombosis and Haemostasis (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Natural Sciences and Engineering Research Council of Canada
Grant: RGPIN-2021-03366
National Institutes of Health
Grant: 1OT2HL156812
National Institutes of Health
Grant: K23HL150315
National Institutes of Health
Grant: OTA-20-011
NIDDK NIH HHS
Grant: R01 DK125786
NIDDK NIH HHS
Grant: R01 DK126685
NHLBI NIH HHS
Grant: R01 HL144566
NHLBI NIH HHS
Grant: OT2 HL156812
NCATS NIH HHS
Grant: UL1 TR001445
Keywords